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ABSTRACT 
The endocannabinoids are cannabinoids synthesized by mammalian tissues. These 
compounds are closely related to the regulation of the male reproductive system. 
However, little is known about the effects produced by 2-arachidonoylglycerol (2AG) 
on in vitro human sperm functions. This study was undertaken to determine the effects 
produced by 2AG on fresh human sperm and in the capacitation technique. Semen 
samples from healthy young men were exposed to different concentrations of 2AG 
before and during capacitation technique. In this work, we have demonstrated that 2AG 
induces the spontaneous acrosome reaction and reduces progressive motility in fresh 
human sperm.	During the capacitation technique, sperm becomes more sensitive to low 
concentrations of 2AG, triggering the acrosome reaction and inhibiting protein 
phosphorylation. In summary, 2AG affects the in vitro functionality of human sperm by 
reducing motility, inhibiting capacitation and triggering the acrosome reaction.  
 
KEY WORDS: acrosome reaction, arachidonoylglycerol, endocannabinoid, noladin, 
protein phosphorylation 
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INTRODUCTION 
Marijuana is the most widely consumed illicit drug worldwide, used by about 180 
million people (UNDOC, 2013). In addition, the active principle of marijuana is used as 
a therapeutic compound to treat diseases such as multiple sclerosis (Vaney et al., 2004; 
Zajicek and Apostu, 2011) and Alzheimer's disease (Campbell and Gowran, 2007; 
Martin-Moreno et al., 2011), and to mitigate the adverse effects of cancer chemotherapy 
(Cotter, 2009; Van Ryckeghem and Van Belle, 2010). Thus, many people are also 
exposed to the components of marijuana, without having consumed the drug for 
recreational purposes. The substances responsible for the pharmacological effects of the 
marijuana plant (Cannabis sativa) are jointly referred to as cannabinoids. However, 
mammalian tissues also produce cannabinoids, called endocannabinoids, including 2-
arachidonoylglycerol (2AG) and arachidonoylethanolamide or anandamide (AEA) 
(Mechoulam et al., 1995; Howlett et al., 2002). Cannabinoids and endocannabinoids 
produce their effects by binding to two types of receptors, cannabinoid receptor 1 (CB1) 
and cannabinoid receptor 2 (CB2). CB1 and CB2 distribution is highly diverse, and 
includes mammals (Mouslech and Valla, 2009), fish (Yamaguchi et al., 1996), 
invertebrates (Matias et al., 2001) and higher plants (Faure et al., 2009).	In humans, 
CB1 is more abundant in the central nervous system (Matsuda et al., 1990) and 
peripheral tissues such as heart (Thakur et al., 2005), liver (Howlett et al., 2010), uterus 
(Fride, 2004) and testis (Cacciola et al., 2008), whereas CB2 is primarily found in the 
immune system (Howlett et al., 2002).	Initially it was thought that human sperm only 
expressed CB1 (Rossato et al., 2005), but the presence of CB2 has also subsequently 
been demonstrated in the sperm plasma membrane (Agirregoitia et al., 2010). 
Endocannabinoids and their receptors form part of the endocannabinoid system, which 
is involved in many functions of several systems, including the reproductive system 
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(Schuel and Burkman, 2005; Wang et al., 2006; Taylor et al., 2007).	For example, in the 
male reproductive system, cannabinoids affect spermatogenesis by lowering LH and 
testosterone levels (Kolodny et al., 1974; Cone et al., 1986). Furthermore, AEA has 
been shown to reduce sperm motility and affect the acquisition of motility in the 
epididymis (Rossato et al., 2005; Ricci et al., 2007). Endocannabinoids are also 
intimately related to capacitation and the acrosome reaction. For example, it has been 
demonstrated that AEA blocks the acrosome reaction in human (Rossato et al., 2005), 
boar (Maccarrone et al., 2005) and sea urchin spermatozoa (Chang et al., 1993). 
Furthermore, capacitation produces biochemical and molecular changes that lead to 
hyperactivated sperm motility (Suarez and Ho, 2003), intracellular calcium 
accumulation (Baldi et al., 1991), cytoskeleton reorganization (Brener et al., 2003; 
Francou et al., 2013) and increased protein phosphorylation (Visconti et al., 2011). In 
this respect, Maccarrone et al. (Maccarrone et al., 2005) have demonstrated that AEA 
inhibits calcium-related changes in boar spermatozoa capacitation. Furthermore, 
methanandamide (an AEA analog) produces a significant reduction in the percentage of 
human sperm with hyperactivated motility (Schuel et al., 2002). However, little is 
known about the effects produced by 2AG on in vitro human sperm functions. Thus, the 
main objective of this study was to determine the effects produced by this potent 
endocannabinoid on fresh human sperm and in the capacitation process. 
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MATERIALS AND METHODS 
Samples collection 
Semen samples were collected from healthy donors (aged 18-35 years old; n=15) after 
3-4 days of sexual abstinence. Samples were allowed to liquefy at 37°C for 30 min 
before processing. Assessment of sperm concentration, semen volume, liquefaction, pH, 
motility, viability and morphology confirmed that samples were normozoospermic, in 
accordance with WHO guidelines (World Health Organization, 2010). Donors gave 
written consent to use their semen samples	 for scientific purposes. The study protocol 
and informed consent were reviewed and approved by the Institutional Review Board. 
 
Assays on fresh sperm.  
Seminal plasma was removed from each fresh sample by washing twice with HEPES 
sodium salt (21 mmol/l, Sigma Aldrich). The sample was divided into aliquots and then 
incubated with different concentrations of 2AG (Cayman Chemical Company, MI, 
USA): 0.01, 0.1, 1, 10 and 100 µM. Control was performed by omitting the 
endocannabinoids. The concentration of organic vehicle was maintained at a constant 
level in all experiments. Samples were incubated at 37 ºC for 1, 2 and 4 hours and the 
motilily, viabiliy and acrosme reaction was evaluated as described below. 
Assays during the swim-up technique.  
The swim-up technique was performed according to Ricci et. al. (Ricci et al., 2009). 
Thus, each sample was divided into six Falcon tubes and then washed in HAM F-10 
(Gibco, Invitrogen) supplemented with HSA (1% Human Serum Albumin, 0.003% 
sodium piruvate, 0.36% sodium lactate, 0.2% sodium bicarbonate) at 37°C and 
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centrifuged at 300 g for 10 min. The supernatant was discarded and the pellet 
resuspended in 0.5 ml of fresh media adding 2AG to obtain concentrations of 0.01, 0.1, 
1, 10 and 100 μM. The addition of 2AG was omitted for the control and the 
concentration of organic vehicle was maintained at a constant level in all experiments.	
These samples were incubated at an angle of 45 degrees and 37°C in a 5% CO2 
atmosphere for 2 hours. Sperm was selected by carefully collecting the top supernatant 
layer prior the assessment of tyrosine phosphorylation and evaluation of acrosome 
reaction. 
.  
Motility and Viability. 
Motility was graded as progressive motility, non-progressive motility, and immotility; 
using a phase contrast microscope in accordance with WHO guidelines (World Health 
Organization, 2010). Sperm viability was assessed using the eosin-nigrosin technique 
(Bjorndahl et al., 2003; World Health Organization, 2010). Eosin-nigrosin staining was 
performed by mixing 10 μL of sample with 10 μL of eosin Y solution (0.5 % w/v 
diluted in 0.9 % w/v of sodium chloride; CI 45380, Panreac química SAU, Barcelona, 
ES). Samples were incubated for 1 min before adding 10 μL of nigrosin, which acted as 
a contrast. A slide extension was made and allowed to dry at room temperature.	A count 
of live sperm (white, without eosin staining) and dead sperm (pink, with eosin staining) 
was performed by bright field microscopy (40x magnification) using 500 sperm cells 
for each sample. 
Evaluation of acrosome reaction 
Acrosomal status was evaluated in fresh and swim-up selected sperm. The technique 
used was fluorescein isothiocyanate-conjugated Pisum sativum agglutinin labeling 
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(FITC-PSA)(Cross and Meizel, 1989). For this, the fixed spermatozoa (methanol, -20 
ºC for 15 min) were incubated with FITC-PSA (1:20 dilution; L0770, Sigma Aldrich) 
for 30 min at room temperature in the dark. Samples were washed with PBS (3 x 5 min) 
and mounted with 5 μL of Vectashield mounting medium (Vector Labs, Burlingame, 
CA) with 4’,6-diamidino-2-phenyilindole (DAPI, 1% v/v; Sigma-Aldrich). FITC 
fluorescence was evaluated in 400 sperm cells from each sample using a confocal 
microscope LEICA SP2 (Leica Microsystems). 
Phosphorylation of tyrosine residues 
Phosphorylation of tyrosine residues was only evaluated in swim-up selected sperm. 
Indirect immunofluorescence was carried out on fixed sperm (methanol, -20ºC for 15 
min). Samples were blocked with 1% BSA in PBS for 30 min at room temperature and 
subsequently incubated with the monoclonal anti-phosphotyrosine antibody (Sigma-
Aldrich; dilution 1:500). The antiserum was diluted in 1% BSA in PBS and incubated 
overnight at 4°C. Samples were washed in PBS for 15 min (3x5 min) and afterwards 
incubated for 1 h at room temperature with DyL 488-conjugated donkey anti-mouse 
IgG (Jackson Immuno Research Europe Ltd, Suffolk, UK). Samples were then rinsed in 
PBS for 15 min and mounted with 5 μL of Vectashield mounting medium (Vector Labs) 
with 4’,6-diamidino-2-phenyilindole (DAPI, 1% v/v; Sigma-Aldrich). Negative controls 
were performed by omitting either primary or secondary antibody. In addition, the 
specificity of anti-phosphotyrosine antibody was demonstrated using a specific 
phosphotyrosine antibody inhibitor (O-phospho-L-tyrosine conjugated to BSA, Sigma-
Aldrich). The fluorescence signal was evaluated in 400 sperm cells from each sample 
using a confocal microscope LEICA SP2 (Leica Microsystems).		
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Image processing and statistical analysis 
Immunofluorescence was analyzed using a Leica TCS SP2 confocal laser scanning 
microscope (Leica Microsystems). DyLight 488 and FITC were excited using the 
488nm line of an Argon ion laser. For DAPI detection the 405nm line of a diode-
coupled laser was used. Immunofluorescence images were then processed with Leica 
TCS SP2-PC software.  
To examine differences between the means, an independent ANOVA and Bonferroni 
post-hoc test was performed using SPSS software (V15.0, IBM). Data are expressed as 
the mean ± SEM and p < 0.05 was considered statistically significant. 
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RESULTS 
 
Effects of 2AG on fresh sperm: viability, motility and acrosome reaction. 
Statistical analysis showed that none of the 2AG tested concentrations caused a 
significant reduction in sperm viability compared to control (Fig. 1A). However,	2AG-
100 µM had important effects on motility when the sample was incubated during 2 and 
4 hours. Progressive motility was significantly lower in 2AG-100 µM than control 
(Fig.1B), and the immotile sperm was significantly higher in 2AG-100 µM than control 
(Fig. 1C). Non-progressive motility was not altered by 2AG concentrations analyzed 
(no significant differences with control). 
A high percentage of spermatozoa with an intact acrosome are desirable in fresh 
samples.	Treatment of the samples with progressive concentrations of 2AG caused an 
increase in the percentage of acrosome-reacted sperm, which was statistically 
significant for 2AG-100 μM (during 2 and 4 incubation hours). However, 2AG had no 
effect on acrosomal exocytosis at concentrations below 100 μM (no significant 
differences with control) (Fig. 1D).   
Our data demonstrated that 1 hour incubation of 2AG produces no significant effects on 
in vitro sperm functions. However, no significant differences between 4 hours versus 2 
hours incubation were found (Fig. 1). Thus, we selected 2 hours as optimal incubation 
time to observe the 2AG effects on sperm during swim-up experiments.  
 
Fig 1. near here 
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2AG effects on swim-up technique: tyrosine phosphorylation and acrosome 
reaction. 
The endocannabinoid effect on swim-up technique was evaluated by adding different 
concentrations of 2AG to capacitation culture media. The percentage of acrosome-
reacted sperm was evaluated by FITC-PSA technique and confocal images were 
obtained (Fig. 2A). The percentage of acrosome reacted sperm was higher with 2AG-10 μM (20.0 ± 2.6 %) and 2AG-100 μM (99.3 ± 0.2 %) than control (7.51 ± 1.2 %) (Fig. 
2B). 
Confocal analysis shows phosphorylation of tyrosine residues is produced mainly in 
flagellar proteins of human spermatozoa (Fig 2C). No immunofluorescent signal was 
found in negative controls. The graph shows that the percentage of sperm with tyrosine 
phosphorylation decreased when 2AG was added during capacitation technique (2AG-
10 μM, 14.8 ± 1.8 %; 2AG-100 μM, 13.3 ± 2.0 %; control; 21.0 ± 1.0 %) (Fig. 2D). 
 
Fig 2. near here 
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DISCUSSION 
Our data show that 2AG (100 µM) decreased progressive motility without affecting the 
viability of fresh sperm. Other authors demonstrated that from a concentration of 
0.1μM, anandamide decreases human sperm motility (Rossato et al., 2005). Moreover, 
2AG levels are high in mouse spermatozoa isolated from the caput epididymis, where 
these do not move, and decreases dramatically in spermatozoa isolated from the cauda 
epididymis (Cobellis et al., 2010). These studies suggest that endocannabinoids exert a 
tight control on sperm motility. However, the mechanism by which these compounds 
affect motility is poorly understood.	 In this sense, a recent study has shown that 2AG 
inhibits the cationic channel of sperm (CatSper) (Miller et al., 2016) and the CatSperI 
expression is related with human sperm motility (Tamburrino et al., 2015). Thus, these 
authors demonstrated that CatSperI protein expression was reduced in 
asthenozoospermic samples and was significantly correlated with total and progressive 
motility. 
Our results also show that the highest concentration of 2AG caused an increase in the 
percentage of acrosome-reacted sperm. In this sense, an early acrosome reaction, prior 
to contact with the oocyte, will abrogate sperm fertilizing ability (Yanagimachi, 1989). 
In contrast to the effect of 2AG, anandamide inhibits the acrosome reaction in human 
(Schuel et al., 2002; Rossato et al., 2005), boar (Maccarrone et al., 2005) and sea urchin 
spermatozoa (Schuel et al., 1994). However, the molecular mechanisms by which 
endocannabinoids affect the acrosome reaction are still poorly understood.	 In this 
respect, several studies have shown that anandamide is also able to bind transient 
receptor potential vanilloid 1 (TRPV1), a nonselective cation channel activated by 
capsaicin (De Petrocellis et al., 2001; Van Der Stelt and Di Marzo, 2004; Francavilla et 
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al., 2009). Additionally, activation of TRPV1 stabilizes the acrosomal membrane and 
inhibits the spontaneous acrosome reaction (Wang et al., 2006). In contrast to 
anandamide, 2AG does not have the capacity to activate TRPV1 (Szallasi and 
Blumberg, 1999; Van Der Stelt and Di Marzo, 2004). Moreover, an increase in 
intracellular calcium is a molecular requirement to trigger the acrosome reaction (Baldi 
et al., 1996; Breitbart, 2002), and this increase mainly comes through calcium channels 
in the plasma membrane of sperm cells . Interestingly, endocannabinoids have the 
capacity to regulate the opening of voltage-sensitive calcium channels (Chemin et al., 
2001). In fact, different CB1 or CB2 agonists may play a key role in the calcium influx 
by producing antagonistic effects with respect to the acrosome reaction. 	
Sperm protein phosphorylation was lower when 2AG (10 and 100 µM) was added 
during the swim-up technique than in control. The increase in phosphorylation of 
tyrosine residues is one of the main molecular events that occur during capacitation 
(Visconti et al., 1995; Barbonetti et al., 2010). Moreover, our results are consistent with 
previous reports which have shown that anandamide reduces the percentage of 
capacitated sperm in boar (Maccarrone and Wenger, 2005) and human (Rossato et al., 
2005). Regarding the cellular mechanism, several studies have demonstrated that 
activation of cannabinoid receptors inhibits adenylyl cyclase, the enzyme necessary to 
increase intracellular levels of cAMP (Vogel et al., 1993; Visconti et al., 1995; Howlett 
et al., 2002). In turn, low levels of cAMP inhibit activation of protein kinase A (PKA) 
which, through other phosphorylases, triggers the protein phosphorylation cascade 
observed during capacitation (Visconti et al., 2002; Harrison, 2004). Thus, 2AG could 
inhibit capacitation through the adenylyl cyclase/cAMP/PKA pathway. 
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In conclusion, our results suggest that in vitro studies 2AG decreases motility, triggers 
the acrosome reaction and inhibits protein phosphorylation. Thus, this endocannabinoid 
could impair fertility due to the important effects it has on sperm physiology. 
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FIGURE LEGENDS 
Figure 1.  2AG effect on fresh sperm. The graphs show that 2AG did not cause a 
significant reduction in sperm viability compared to control after 1,2 or 4 incubation 
hours (A). 2AG-100 μM only had an effect on sperm functions after 2 and 4 incubation 
hours, producing a significant decrease in progressive motility (B), a significant 
increase in immotility (C) and acrosome reacted sperm (D). Values are mean ± SEM. 
Significant difference versus control, (*) p < 0.05; (**) p < 0.01.  
 
Figure 2.  2AG effect during swim-up technique. The confocal micrograph shows an 
acrosome-reacted sperm (AR +, green-unlabeled) and an acrosome intact sperm (AR -, 
green-labeled) (A); and the percentage of acrosome-reacted sperm was only 
significantly higher with 2AG-10 μM and 100 μM (B). The spermatozoa with tyrosine 
phosphorylation (green-labeled flagellum) and without tyrosine phosphorylation 
(unlabeled) were observed by confocal analysis (C). The percentage of sperm with 
tyrosine phosphorylation was lower than control, when 2AG-10 μM and 100 μM were 
added (D). Values are mean ± SEM. Significant difference versus control, (*) p < 0.05. 
Scale bars 5μm. 
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